Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 3
1973 9
1974 3
1975 4
1976 7
1977 8
1978 6
1979 8
1980 10
1981 6
1982 12
1983 12
1984 7
1985 12
1986 10
1987 4
1988 6
1989 6
1990 5
1991 7
1992 3
1993 7
1994 6
1995 14
1996 11
1997 13
1998 12
1999 10
2000 8
2001 7
2002 10
2003 13
2004 6
2005 5
2006 8
2007 13
2008 6
2009 7
2010 3
2011 5
2012 7
2013 9
2014 3
2015 2
2016 2
2017 3
2018 4
2019 4
2020 3
2021 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.
Woelk H, Schläfke S. Woelk H, et al. Phytomedicine. 2010 Feb;17(2):94-9. doi: 10.1016/j.phymed.2009.10.006. Epub 2009 Dec 3. Phytomedicine. 2010. PMID: 19962288 Clinical Trial.
In this study, the efficacy of a 6-week-intake of silexan compared to lorazepam was investigated in adults with GAD. The primary target variable was the change in the Hamilton Anxiety Rating Scale (HAM-A-total score) as an objective measurement of the severity of …
In this study, the efficacy of a 6-week-intake of silexan compared to lorazepam was investigated in adults with GAD. The primary targ …
Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial.
Hui D, Frisbee-Hume S, Wilson A, Dibaj SS, Nguyen T, De La Cruz M, Walker P, Zhukovsky DS, Delgado-Guay M, Vidal M, Epner D, Reddy A, Tanco K, Williams J, Hall S, Liu D, Hess K, Amin S, Breitbart W, Bruera E. Hui D, et al. JAMA. 2017 Sep 19;318(11):1047-1056. doi: 10.1001/jama.2017.11468. JAMA. 2017. PMID: 28975307 Free PMC article. Clinical Trial.
The lorazepam + haloperidol group required less median rescue neuroleptics (2.0 mg) than the placebo + haloperidol group (4.0 mg) (median difference, -1.0 mg [95% CI, -2.0 to 0]; P = .009) and was perceived to be more comfortable by both blinded caregivers and nurses (care …
The lorazepam + haloperidol group required less median rescue neuroleptics (2.0 mg) than the placebo + haloperidol group (4.0 mg) (me …
Lorazepam in the treatment of anxiety.
Haider I. Haider I. Curr Med Res Opin. 1972;1(2):70-3. doi: 10.1185/03007997209111147. Curr Med Res Opin. 1972. PMID: 4589020 Clinical Trial. No abstract available.
The effect of lorazepam on pain and anxiety in abortion.
Wiebe E, Podhradsky L, Dijak V. Wiebe E, et al. Contraception. 2003 Mar;67(3):219-21. doi: 10.1016/s0010-7824(02)00516-4. Contraception. 2003. PMID: 12618257 Clinical Trial.
The outcome measures were 11-point verbal pain scales of pain during the abortion and anxiety measured before premedication and during the abortion. The mean anxiety and pain scores did not differ significantly in the lorazepam and placebo groups of the rando …
The outcome measures were 11-point verbal pain scales of pain during the abortion and anxiety measured before premedication and durin …
Implication of UGT2B15 Genotype Polymorphism on Postoperative Anxiety Levels in Patients Receiving Lorazepam Premedication.
Mijderwijk H, Klimek M, van Beek S, van Schaik RH, Duivenvoorden HJ, Stolker RJ. Mijderwijk H, et al. Anesth Analg. 2016 Nov;123(5):1109-1115. doi: 10.1213/ANE.0000000000001508. Anesth Analg. 2016. PMID: 27622723 Clinical Trial.
RESULTS: The anxiety difference was complex in that the interaction of lorazepam and UGT2B15 genotype status also was dependent on the joint effect of patient sex and preoperative anxiety score (F = 7.15, P = .008). ...CONCLUSIONS: UGT2B15 genotype contribute …
RESULTS: The anxiety difference was complex in that the interaction of lorazepam and UGT2B15 genotype status also was dependen …
Efficacy of ketamine for initial control of acute agitation in the emergency department: A randomized study.
Lin J, Figuerado Y, Montgomery A, Lee J, Cannis M, Norton VC, Calvo R, Sikand H. Lin J, et al. Am J Emerg Med. 2021 Jun;44:306-311. doi: 10.1016/j.ajem.2020.04.013. Epub 2020 Apr 11. Am J Emerg Med. 2021. PMID: 32340820 Clinical Trial.
Adult patients with combative agitation were randomized to ketamine (4 mg/kg IM or 1 mg/kg IV) or haloperidol/lorazepam (haloperidol 5-10 mg IM or IV + lorazepam 1-2 mg IM or IV). ...Significantly more patients who received ketamine compared to haloperidol/loraze …
Adult patients with combative agitation were randomized to ketamine (4 mg/kg IM or 1 mg/kg IV) or haloperidol/lorazepam (haloperidol …
Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge.
Schunck T, Mathis A, Erb G, Namer IJ, Demazières A, Luthringer R. Schunck T, et al. J Psychopharmacol. 2010 May;24(5):701-8. doi: 10.1177/0269881109104864. Epub 2009 May 21. J Psychopharmacol. 2010. PMID: 19460871 Clinical Trial.
Human models of anxiety are useful to develop new effective anxiolytics. The objective of this study was to use functional magnetic resonance imaging (fMRI) to test the hypothesis that a single dose of lorazepam modifies brain activation during an anxiety cha …
Human models of anxiety are useful to develop new effective anxiolytics. The objective of this study was to use functional magnetic r …
Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.
Laakmann G, Schüle C, Lorkowski G, Baghai T, Kuhn K, Ehrentraut S. Laakmann G, et al. Psychopharmacology (Berl). 1998 Apr;136(4):357-66. doi: 10.1007/s002130050578. Psychopharmacology (Berl). 1998. PMID: 9600581 Clinical Trial.
In this double-blind, placebo-controlled 10-week trial, the anxiolytic properties of the nonbenzodiazepine buspirone were compared with the benzodiazepine lorazepam and placebo in 125 outpatients with generalized anxiety disorder according to DSM-III. ...Lorazepa …
In this double-blind, placebo-controlled 10-week trial, the anxiolytic properties of the nonbenzodiazepine buspirone were compared with the …
A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
Ruiz AT. Ruiz AT. J Clin Psychiatry. 1983 Feb;44(2):60-2. J Clin Psychiatry. 1983. PMID: 6131066 Clinical Trial.
In a 4-week double-blind study of 53 psychoneurotic outpatients, alprazolam and lorazepam appeared to be equally safe and effective in relieving anxiety symptoms. ...
In a 4-week double-blind study of 53 psychoneurotic outpatients, alprazolam and lorazepam appeared to be equally safe and effective i …
Comparison of lorazepam and diazepam in anxiety neurosis.
Khorana AB, Khorana S, Nanivadekar AS. Khorana AB, et al. Curr Med Res Opin. 1973;1(4):192-8. doi: 10.1185/03007997309111666. Curr Med Res Opin. 1973. PMID: 4589626 Clinical Trial. No abstract available.
338 results